{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T18:46:12Z","timestamp":1648665972881},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1991,7,1]],"date-time":"1991-07-01T00:00:00Z","timestamp":678326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer and Clinical Oncology"],"published-print":{"date-parts":[[1991,7]]},"DOI":"10.1016\/0277-5379(91)90136-2","type":"journal-article","created":{"date-parts":[[2004,4,17]],"date-time":"2004-04-17T22:00:02Z","timestamp":1082239202000},"page":"866-870","source":"Crossref","is-referenced-by-count":5,"title":["Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide"],"prefix":"10.1016","volume":"27","author":[{"given":"A.L.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Holborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0277-5379(91)90136-2_BIB1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0002-9343(69)90071-0","article-title":"Alkylating agents in bronchogenic carcinoma","volume":"46","author":"Green","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/0277-5379(91)90136-2_BIB2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9343(84)90095-0","article-title":"Long-term survival and toxicity in small cell lung cancer: a South-West Oncology Group Study","volume":"77","author":"Livingstone","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/0277-5379(91)90136-2_BIB3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.1990.8.3.396","article-title":"Ten-year survival of patients with small cell lung cancer treated with combination chemotherapy with or without irradiation","volume":"8","author":"Johnson","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/0277-5379(91)90136-2_BIB4","first-page":"519","article-title":"Intensive induction therapy for small cell carcinoma of the lung","volume":"63","author":"Abeloff","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0277-5379(91)90136-2_BIB5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00434349","article-title":"High dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma","volume":"14","author":"Smith","year":"1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/0277-5379(91)90136-2_BIB6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1200\/JCO.1987.5.5.703","article-title":"High-dose induction chemotherapy with cyclophosphamide, etoposide and cisplatin for extensive-stage small cell lung cancer","volume":"5","author":"Johnson","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/0277-5379(91)90136-2_BIB7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1200\/JCO.1990.8.5.899","article-title":"Carboplatin, etoposide and ifosfamide as intensive chemotherapy for small cell lung cancer","volume":"8","author":"Smith","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/0277-5379(91)90136-2_BIB8","first-page":"43","article-title":"Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer","volume":"69","author":"Smith","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0277-5379(91)90136-2_BIB9","first-page":"239","article-title":"Vincristine in the treatment of small cell anaplastic carcinoma of the lung","volume":"60","author":"Dombernowsky","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0277-5379(91)90136-2_BIB10","first-page":"413","article-title":"Randomised study of high dose low dose methotrexate in the treatment of extensive small cell lung cancer","volume":"73","author":"Hande","year":"1982","journal-title":"Am J Cancer"},{"key":"10.1016\/0277-5379(91)90136-2_BIB11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00254546","article-title":"Doxorubicin, cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer","volume":"7","author":"Aisner","year":"1982","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/0277-5379(91)90136-2_BIB12","series-title":"A randomised study of etoposide given orally by one day or five days schedule together with intravenous Adriamycin and cyclophosphamide","first-page":"172","article-title":"Extensive stage small cell carcinoma of the bronchus","volume":"19","author":"Mead","year":"1987"},{"key":"10.1016\/0277-5379(91)90136-2_BIB13","series-title":"A study by the EORTC Lung Cancer Working Party (Belgium)","first-page":"71","article-title":"Combination chemotherapy with Adriamycin, etoposide and cyclophosphamide for small cell carcinoma of the lung","volume":"56","author":"Klastersky","year":"1985"},{"key":"10.1016\/0277-5379(91)90136-2_BIB14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Millar","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/0277-5379(91)90136-2_BIB15","series-title":"Analysis and examples","first-page":"1","article-title":"Design and analysis of randomised clinical trials requiring prolonged observation of each patient","volume":"35","author":"Peto","year":"1977"},{"key":"10.1016\/0277-5379(91)90136-2_BIB16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1200\/JCO.1990.8.2.209","article-title":"Is prophylactic cranial irradiation indicated in small cell lung cancer?","volume":"8","author":"Fleck","year":"1990","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0277537991901362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0277537991901362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T22:28:55Z","timestamp":1550010535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0277537991901362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1991,7]]}},"alternative-id":["0277537991901362"],"URL":"https:\/\/doi.org\/10.1016\/0277-5379(91)90136-2","relation":{},"ISSN":["0277-5379"],"issn-type":[{"value":"0277-5379","type":"print"}],"subject":[],"published":{"date-parts":[[1991,7]]}}}